Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 27006386

Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2016 Jun 2
First author
Wang W

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2016 Jun 2;127(22):2661-2. doi: 10.1182/blood-2016-04-708206.
    note
    Source null
    related pmid
    27257178
    relationship
    Comment in

Authors and identifiers

  1. name
    Wang W
    type
    Author
  2. name
    Cortes JE
    type
    Author
  3. name
    Tang G
    type
    Author
  4. name
    Khoury JD
    type
    Author
  5. name
    Wang S
    type
    Author
  6. name
    Bueso-Ramos CE
    type
    Author
  7. name
    DiGiuseppe JA
    type
    Author
  8. name
    Chen Z
    type
    Author
  9. name
    Kantarjian HM
    type
    Author
  10. name
    Medeiros LJ
    type
    Author
  11. name
    Hu S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wang W
    type
    Author
  2. name
    Cortes JE
    type
    Author
  3. name
    Tang G
    type
    Author
  4. name
    Khoury JD
    type
    Author
  5. name
    Wang S
    type
    Author
  6. name
    Bueso-Ramos CE
    type
    Author
  7. name
    DiGiuseppe JA
    type
    Author
  8. name
    Chen Z
    type
    Author
  9. name
    Kantarjian HM
    type
    Author
  10. name
    Medeiros LJ
    type
    Author
  11. name
    Hu S
    type
    Author
bibliography ids
  1. nci-bib-076e67da09fcf854fb03d90d
book metadata
content sha256
0129c5937dc299481b89f76567c4e04d2d838d3f4b21d07358641a3ff1080e91
document type
citation
dois
  1. 10.1182/blood-2016-01-690230
electronic publication date
display
2016 Mar 22
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27006386
immutable id
pubmed:27006386@0129c5937dc299481b89f76567c4e04d2d838d3f4b21d07358641a3ff1080e91
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
22
name
Blood
nlm unique id
7603509
pages
2742-50
volume
127
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2016 Jun 2;127(22):2661-2. doi: 10.1182/blood-2016-04-708206.
    note
    Source null
    related pmid
    27257178
    relationship
    Comment in
outcomes validated
false
pmid
27006386
provenance
batch id
fe5a46c92522c34737e8
provider
NCBI PubMed ESummary
record sha256
f13fba0378871d32b0fb9e5c4e00f6a3e2fa0eb808f3b83d2acc0cdbdc057b5c
response sha256
2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
retrieved at
2026-09-09T23:47:17.939307+00:00
publication date
display
2016 Jun 2
precision
day
year
2016
publication types
  1. Clinical Trial
  2. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27006386/
title
Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Preserved source evidence · Independent clinical review pending · Not medical advice